“When the history of COVID is written, the U.S. gov’t promotion of remdesivir, which reaped $2.8B...but doesn’t save lives, shorten hospital stays or avoid..ventilators, will be contrasted with its failure to act on a cheap generic that does..#Ivermectin.”